It also leads to changes in endocrine hormones (low levels of progesterone and high levels of luteinizing hormone, testosterone, estrogen, and prolactin) and metabolic disorders  such as dyslipidemia, obesity, inflammation, and high blood pressure (Abasian et al., 2018). Here, PRL is linked to obesity due to melanocortin 4 receptor deficiency.